Clinical Trial Update: Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial [NA]

View source ↗

Summary

A Phase III randomized trial comparing hippocampal-sparing whole-brain radiation versus stereotactic radiation in patients with 5-20 brain metastases; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Brain Metastases | NA | Status: ACTIVE_NOT_RECRUITING